PIEPER STEVEN (Chief Financial Officer) sold 3.2% of their position (45K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $383.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/7/2026ACC: 0001875714-26-000007
Officer· Chief Financial Officer
Since Oct 2021
-45K
Net shares
Net seller
$383.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−17.40K
Price / share
$8.50
Trade value
$147.90K
% of position
1.2%
7/6/2026
1.41M→1.39M
Common Stock
Direct
Shares
−27.60K
Price / share
$8.52
Trade value
$235.28K
% of position
2.0%
7/7/2026
1.39M→1.37M
Total
Net shares
−45K
Net value
-$383.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | S · Sale | −17.40K | $8.50 | $147.90K | 1.2% | 1.41M | 1.39M |
| Common Stock Direct | 7/7/2026 | S · Sale | −27.60K | $8.52 | $235.28K | 2.0% | 1.39M | 1.37M |
| Total | −45K | -$383.18K | ||||||
Derivative Transactions0
No derivative transactions reported